Monika Doll

408 total citations
19 papers, 326 citations indexed

About

Monika Doll is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Monika Doll has authored 19 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Monika Doll's work include Peroxisome Proliferator-Activated Receptors (7 papers), NF-κB Signaling Pathways (5 papers) and Inflammatory mediators and NSAID effects (4 papers). Monika Doll is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (7 papers), NF-κB Signaling Pathways (5 papers) and Inflammatory mediators and NSAID effects (4 papers). Monika Doll collaborates with scholars based in Germany and United States. Monika Doll's co-authors include Markus Meißner, Roland Kaufmann, Igor Hrgović, Stefan Kippenberger, Jens Gille, Andreas Pinter, Johannes Kleemann, Nadja Zöller, H. Schmutterer and Xiao‐Fan Wang and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Investigative Dermatology and Cells.

In The Last Decade

Monika Doll

18 papers receiving 323 citations

Peers

Monika Doll
Young Mi Kim South Korea
Zhi Xu China
Jung Yoo South Korea
Monika Doll
Citations per year, relative to Monika Doll Monika Doll (= 1×) peers Jiali Yang

Countries citing papers authored by Monika Doll

Since Specialization
Citations

This map shows the geographic impact of Monika Doll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monika Doll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monika Doll more than expected).

Fields of papers citing papers by Monika Doll

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monika Doll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monika Doll. The network helps show where Monika Doll may publish in the future.

Co-authorship network of co-authors of Monika Doll

This figure shows the co-authorship network connecting the top 25 collaborators of Monika Doll. A scholar is included among the top collaborators of Monika Doll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monika Doll. Monika Doll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Doll, Monika, Nadja Zöller, Frank Schnütgen, et al.. (2025). Estrogen receptor β stimulation as a possible novel therapeutic target for cutaneous T-cell lymphoma. Blood Advances. 9(11). 2651–2662.
2.
Hrgović, Igor, Monika Doll, Thilo Jakob, et al.. (2023). Arsenic Trioxide Decreases Lymphangiogenesis by Inducing Apoptotic Pathways and Inhibition of Important Endothelial Cell Receptors. Current Issues in Molecular Biology. 46(1). 67–80. 2 indexed citations
3.
Hrgović, Igor, Johannes Kleemann, Monika Doll, et al.. (2021). Evaluation of 2‑methoxyestradiol serum levels as a potential prognostic marker in malignant melanoma. Molecular and Clinical Oncology. 15(1). 141–141. 2 indexed citations
4.
Doll, Monika, et al.. (2021). Apremilast effectively inhibits TNFα‐induced vascular inflammation in human endothelial cells. Journal of the European Academy of Dermatology and Venereology. 36(2). 237–246. 26 indexed citations
5.
Doll, Monika, Roland Kaufmann, Panagiotis Balermpas, et al.. (2019). Dimethylfumarate Inhibits Colorectal Carcinoma Cell Proliferation: Evidence for Cell Cycle Arrest, Apoptosis and Autophagy. Cells. 8(11). 1329–1329. 28 indexed citations
6.
Hrgović, Igor, Monika Doll, Johannes Kleemann, et al.. (2016). The histone deacetylase inhibitor trichostatin a decreases lymphangiogenesis by inducing apoptosis and cell cycle arrest via p21-dependent pathways. BMC Cancer. 16(1). 763–763. 35 indexed citations
7.
Hrgović, Igor, Monika Doll, Victoria Lang, et al.. (2016). Peroxisome proliferator-activated receptor (PPAR) α and δ activators induce ICAM-1 expression in quiescent non stimulated endothelial cells. Journal of Inflammation. 13(1). 27–27. 14 indexed citations
8.
Hrgović, Igor, Monika Doll, Johannes Kleemann, et al.. (2016). Dimethylfumarate inhibits melanoma cell proliferation via p21 and p53 induction and bcl-2 and cyclin B1 downregulation. Tumor Biology. 37(10). 13627–13635. 16 indexed citations
9.
Hrgović, Igor, Monika Doll, Andreas Pinter, et al.. (2016). Histone deacetylase inhibitors interfere with angiogenesis by decreasing endothelial VEGFR‐2 protein half‐life in part via a VE‐cadherin‐dependent mechanism. Experimental Dermatology. 26(2). 194–201. 26 indexed citations
10.
Doll, Monika, Igor Hrgović, Nadja Zöller, et al.. (2015). Dimethylfumarate protects against TNF-α-induced secretion of inflammatory cytokines in human endothelial cells. Journal of Inflammation. 12(1). 49–49. 23 indexed citations
11.
Valesky, Eva, Igor Hrgović, Monika Doll, et al.. (2015). Dimethylfumarate effectively inhibits lymphangiogenesis via p21 induction and G1 cell cycle arrest. Experimental Dermatology. 25(3). 200–205. 15 indexed citations
12.
Starzinski‐Powitz, Anna, Bonnie F. Sloane, Monika Doll, et al.. (2012). PPARα agonist Wy14643 suppresses cathepsin B in human endothelial cells via transcriptional, post-transcriptional and post-translational mechanisms. Angiogenesis. 16(1). 223–233. 9 indexed citations
13.
Starzinski‐Powitz, Anna, Monika Doll, Igor Hrgović, et al.. (2012). Ligand activation of peroxisome proliferator‐activated receptor delta suppresses cathepsin B expression in human endothelial cells in a posttranslational manner. Experimental Dermatology. 21(10). 751–757. 7 indexed citations
14.
Meißner, Markus, et al.. (2011). Suppression of VEGFR2 Expression in Human Endothelial Cells by Dimethylfumarate Treatment: Evidence for Anti-Angiogenic Action. Journal of Investigative Dermatology. 131(6). 1356–1364. 46 indexed citations
15.
Meißner, Markus, Monika Doll, Igor Hrgović, et al.. (2011). AP1-dependent repression of TGFα-mediated MMP9 upregulation by PPARδ agonists in keratinocytes. Experimental Dermatology. 20(5). 425–429. 12 indexed citations
16.
Meißner, Markus, et al.. (2011). Peroxisome proliferator activated receptor-α agonists suppress transforming growth factor-α-induced matrix metalloproteinase-9 expression in human keratinocytes. Clinical and Experimental Dermatology. 36(8). 911–914. 7 indexed citations
17.
Meißner, Markus, Igor Hrgović, Monika Doll, et al.. (2010). Peroxisome Proliferator-activated Receptor δ Activators Induce IL-8 Expression in Nonstimulated Endothelial Cells in a Transcriptional and Posttranscriptional Manner*. Journal of Biological Chemistry. 285(44). 33797–33804. 27 indexed citations
18.
Meißner, Markus, Igor Hrgović, Monika Doll, & Roland Kaufmann. (2010). PPARδ agonists suppress angiogenesis in a VEGFR2-dependent manner. Archives of Dermatological Research. 303(1). 41–47. 22 indexed citations
19.
Schmutterer, H. & Monika Doll. (1993). The marrango or philippine neem tree,Azadirachta excelsa (=A. Integrifoliola): A new source of insecticides with growth-regulating properties. Phytoparasitica. 21(1). 79–86. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026